Top compounds associated with response to CFB


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin gCSI pan-cancer AAC -0.094 0.08
mRNA indisulam CTRPv2 pan-cancer AAC -0.059 0.08
mRNA SB-743921 CTRPv2 pan-cancer AAC -0.059 0.08
mRNA PI-103 CTRPv2 pan-cancer AAC -0.063 0.08
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.09
mRNA Dasatinib CTRPv2 pan-cancer AAC 0.064 0.09
mRNA elocalcitol CTRPv2 pan-cancer AAC -0.06 0.1
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC -0.082 0.1
mRNA Docetaxel gCSI pan-cancer AAC -0.092 0.1
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.1
Download CSV